BroadOak Logo

Acquisition of sales and marketing rights to EpiPen in Canada from Allerex Laboratory

02 May Acquisition of sales and marketing rights to EpiPen in Canada from Allerex Laboratory

May 2, 2024 |
No Comments

Sorry, the comment form is closed at this time.

LinkedIn White  Stay connected

Arrow White  Partner with BroadOak
Investing
Advisory
About
Portfolio
Transactions
News
Contact
Team
Investor Login
Join our newsletter.
Sign up to stay informed about our work.
This field is for validation purposes and should be left unchanged.
2022 © BroadOak Capital Partners, LLC.
All rights reserved.
Member FINRA | SIPC
Business Continuity Disclosure
Privacy Policy